Xiao Shengjue, Wang Zhenwei, Zuo Ronghua, Zhou Yufei, Yang Yiqing, Chen Tian, Liu Naifeng
Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China.
Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
J Inflamm Res. 2023 Mar 6;16:941-961. doi: 10.2147/JIR.S402227. eCollection 2023.
Our research was designed to investigate the relationship between systemic immune inflammation (SII) index and all-cause, cardiovascular disease (CVD), and cancer-related mortality in patients with CVD.
We used the National Health and Nutrition Examination Survey data from 1999 to 2018 to conduct this study. The association between SII index and all-cause, CVD, and cancer-related mortality in patients with CVD was examined using restricted cubic splines (RCS), Cox proportional hazard models, and subgroup analysis, respectively. CVD was defined as a composite of five outcomes of CVD, including coronary heart disease (CHD), congestive heart failure (CHF), angina pectoris, myocardial infarction, and stroke. Additionally, the link between SII index and all-cause, CVD, and cancer-related mortality in patients with a composite of five outcomes of CVD was also explored.
In total, 5329 participants were included. The RCS also showed a U-curve correlation between SII index and the all-cause, CVD, and cancer-related mortality in patients with CVD. As compared with the individuals with lowest quartile of SII index, hazard ratios with 95% confidence intervals for all-cause, CVD, and cancer-related mortality across the quartiles were (1.202 (0.981, 1.474), 1.184 (0.967, 1.450), and 1.365 (1.115, 1.672)), (1.116 (0.815, 1.527), 1.017 (0.740, 1.398), and 1.220 (0.891, 1.670)), and (1.202 (0.981, 1.474), 1.184 (0.967, 1.450), and 1.365 (1.115, 1.672)), respectively, in the full-adjusted model. The SII index also had a U-shaped relationship with all-cause, CVD, and cancer-related mortality in patients with CHD, angina, and myocardial infarction. Additionally, the U-shaped relationship between SII index and all-cause, and cancer-related mortality also exists in CHF, and stroke. However, there was a positive linear correlation between SII index and CVD mortality in patients with CHF, and stroke.
In the United States general population, the correlation between SII index and all-cause, CVD, and cancer-related mortality showed a U-shaped curve in patients with CVD.
我们的研究旨在调查全身免疫炎症(SII)指数与心血管疾病(CVD)患者的全因死亡率、心血管疾病死亡率和癌症相关死亡率之间的关系。
我们使用了1999年至2018年的美国国家健康与营养检查调查数据进行这项研究。分别使用受限立方样条(RCS)、Cox比例风险模型和亚组分析来检验SII指数与CVD患者的全因死亡率、心血管疾病死亡率和癌症相关死亡率之间的关联。CVD被定义为包括冠心病(CHD)、充血性心力衰竭(CHF)、心绞痛、心肌梗死和中风在内的五种CVD结局的综合。此外,还探讨了SII指数与具有五种CVD结局综合的患者的全因死亡率、心血管疾病死亡率和癌症相关死亡率之间的联系。
总共纳入了5329名参与者。RCS还显示SII指数与CVD患者的全因死亡率、心血管疾病死亡率和癌症相关死亡率之间呈U型曲线相关。在完全调整模型中,与SII指数处于最低四分位数的个体相比,各四分位数的全因死亡率、心血管疾病死亡率和癌症相关死亡率的风险比及其95%置信区间分别为(1.202(0.981,1.474)、1.184(0.967,1.450)和1.365(1.115,1.672))、(1.116(0.815,1.527)、1.017(0.740,1.398)和1.220(0.891,1.670))以及(1.202(0.981,1.474)、1.184(0.967,1.450)和1.365(1.115,1.672))。SII指数与冠心病、心绞痛和心肌梗死患者的全因死亡率、心血管疾病死亡率和癌症相关死亡率也呈U型关系。此外,SII指数与CHF和中风患者的全因死亡率和癌症相关死亡率之间也存在U型关系。然而,SII指数与CHF和中风患者的心血管疾病死亡率之间呈正线性相关。
在美国普通人群中,SII指数与CVD患者的全因死亡率、心血管疾病死亡率和癌症相关死亡率之间的相关性呈U型曲线。